Georgia's $14 Million Bioscience Training Center an Offshoot of Baxter's $1 Billion Plant
Georgia's $14 Million Bioscience Training Center an Offshoot of Baxter's $1 Billion Plant
SUGAR LAND--April 17, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It was a definite win for Georgia's burgeoning bioscience sector when Baxter International Corporation (NYSE:BAX) (Deerfield, Illinois) decided to invest $1 billion to construct a 1 million-square-foot plasma fractionation facility with purification and fill/finish suites in Covington, Georgia. In support of the massive project, now under construction, the state is building the $14 million Georgia BioScience Training Center adjacent to the new plant.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Takeda Completes $62 Billion Shire Acquisition, an Industrial Info Market B...
- Top 10 U.S. States Land $37.7 Billion in Active Pharmaceutical-Biotech Indu...
- Pharma-Bio Industry Capital Construction Monitor: Projects Underway in Nort...
- Life-Science New Build Report: 200 North American Sites in Planning Represe...
- Pharma-Biotech Industry Capital Investment Tops $12 Billion for North Ameri...